TGFB1 and neoplasm: Tregs suppress dendritic cell antigen presentation and induce T cell exhaustion within the tumor microenvironment through the secretion of suppressive cytokines, including TGF-β, IL-35, and IL-10, as well as by modulating the expression of inhibitory receptors.